Blog
Bioprocess Scale Down Model (SDM) vs Commercial scale: Introduction, Limitations and Goals
Apr 6, 2026 522
Scale Down Model (SDM) for Bioprocess: Equivalence Test, Outcome, Benefits and Conclusion
Apr 6, 2026 468
Scale Down Model (SDM) for Bioprocess: Equivalence acceptable criteria (EAC)/Practical significant difference (PSD) & Sample Size Calculation
Apr 6, 2026 469
Cell Culture Data Analytics Flow
Apr 6, 2026 503
Bioreactor Scale-Up Strategy: Key Concepts and Approaches
Apr 6, 2026 465
Process Risk Assessment: A Data-Driven FMEA Approach
Apr 6, 2026 417
Design of Experiment (DoE) for Bioprocess- An Introduction
Apr 6, 2026 384
Design of Experiment (DoE) for Bioprocess-Design Evaluation Guide
Apr 6, 2026 356
Blocking in DoE in Bioprocess Development: A Practical and Statistical Perspective
Apr 6, 2026 68
An Introduction to Hybrid Modelling: Concept and Workflow
Apr 6, 2026 66
Tell Us About Your Project
Our team of experienced professionals at Graphtal is ready to transform your project from idea to
reality, ensuring alignment with your organisation goals through advanced data analytics and
predictive modelling.
Let's simplify your work